NTRK2 and Cognitive impairment: Much evidence has accumulated indicating that BDNF-TrkB signaling declines in AD patients and in patients with mild cognitive impairment, and this deficient signaling may even precede the decline of choline acetyltransferase (ChAT) activity [32,33].